Dermata Therapeutics, Inc. (DRMA) stock
DRMANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.62−0.04 (-6.01%)
Close on Nov 13, 2026Market cap $2.50MP/E –Yield –
Dermata Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Dermata Therapeutics's enterprise value was -$1.54M on Nov 11, 2026, against -$2.01M a year earlier. Over the last 5 years it ranged from -$6.19M to $4.48B, with a median of $775.80K.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$1.54M | – |
| 2025 | Dec 31, 2025 | -$2.70M | – |
| 2024 | Dec 31, 2024 | -$3.88M | -117.2% |
| 2023 | Dec 29, 2023 | $22.55M | -98.1% |
| 2022 | Dec 30, 2022 | $1.18B | -66.0% |
| 2021 | Dec 31, 2021 | $3.47B | – |
See a number that looks wrong?